Do proton pump inhibitors protect against cancer progression in GERD?

Proton-Pump Inhibitor Use and the Risk for Community-Acquired Pneumonia

(2013) Monika Sarkar et al.   ANNALS OF INTERNAL MEDICINE

A Rationale for the Use of Proton Pump Inhibitors as Antineoplastic Agents

(2012) Angelo De Milito et al.   CURRENT PHARMACEUTICAL DESIGN

Barrett's esophagus and animal models

(2011) Ryan A. Macke et al.   Annals of the New York Academy of Sciences

Acid suppression increases rates of Barrett’s esophagus and esophageal injury in the presence of duodenal reflux

(2011) Ayman O. Nasr et al.   SURGERY

Proton pump inhibitor therapy in gastro-oesophageal reflux disease decreases the oesophageal immune response but does not reduce the formation of DNA adducts

(2010) P. J. F. DE JONGE et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Adverse effects of proton pump inhibitor drugs: clues and conclusions

(2010) Denis M McCarthy   CURRENT OPINION IN GASTROENTEROLOGY

Rabeprazole Impedes the Development of Reflux-Induced Esophageal Cancer in a Surgical Rat Model

(2010) Tomoharu Miyashita et al.   DIGESTIVE DISEASES AND SCIENCES

Medications (NSAIDs, Statins, Proton Pump Inhibitors) and the Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus

(2010) Dang M. Nguyen et al.   GASTROENTEROLOGY

Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori

(2010) T. Hagiwara et al.   GUT

Safety of the long-term use of proton pump inhibitors

(2010) Alan BR Thomson   WORLD JOURNAL OF GASTROENTEROLOGY

Rabeprazole: a pharmacologic and clinical review for acid-related disorders

(2009) Alia Dadabhai et al.   Expert Opinion On Drug Safety

Lansoprazole, a Proton Pump Inhibitor, Mediates Anti-Inflammatory Effect in Gastric Mucosal Cells through the Induction of Heme Oxygenase-1 via Activation of NF-E2-Related Factor 2 and Oxidation of Kelch-Like ECH-Associating Protein 1

(2009) T. Takagi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Use of Gastrointestinal Proton Pump Inhibitors to Regulate Osteoclast- Mediated Resorption of Calcium Phosphate Cements In Vivo

(2009) A. Sheraly et al.   Current Drug Delivery

Gastric Acid Suppression by Proton Pump Inhibitors as a Risk Factor forClostridium Difficile-Associated Diarrhea in Hospitalized Patients

(2008) Mohammed Aseeri et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Reducing the weight of cancer: mechanistic targets for breaking the obesity–carcinogenesis link

(2008) Stephen D. Hursting et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Proton pump inhibitors: balancing the benefits and potential fracture risks

(2008) J. B. Richards et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Use of proton pump inhibitors and risk of osteoporosis-related fractures

(2008) L. E. Targownik et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Effect of α-tocopherol,N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model

(2008) Jing Hao et al.   INTERNATIONAL JOURNAL OF CANCER

Lansoprazole Protects and Heals Gastric Mucosa from Non-steroidal Anti-inflammatory Drug (NSAID)-induced Gastropathy by Inhibiting Mitochondrial as Well as Fas-mediated Death Pathways with Concurrent Induction of Mucosal Cell Renewal

(2008) Pallab Maity et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Detection ofN-nitroso-bile acids at 285 nm in reverse-phase HPLC

(2008) Yoshio Araki et al.   JOURNAL OF SEPARATION SCIENCE